Global Particle Therapy
Market Report
2024

Particle Therapy Market Report 2024 (Global Edition)

The global particle therapy was valued at USD 483.32 million in 2022 and will reach USD 1.23 billion by 2030, registering a CAGR of 12.4% for the forecast period 2023-2030.

Author Name: Anushka Gore | Report ID: CMR134414 |

The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.

Data Updated: October 2024 | Report Pages: 250+ | Edition: 8th |

PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.

Format:

Rating: 4.8 | Review: 7

| Last Updated: 2023-11-21T12:15:20-06:00

Share your contact details to receive free updated sample copy/pages of the recently published edition of Particle Therapy Market Report 2024.

Global Particle Therapy Market Report 2024 Market Size Split by Type (Proton therapy, Heavy ion therapy), by Application (Treatment, Research), by Product (Cycloclotron, Synchrotron, Synchrocyclotron)...

The global particle therapy was valued at USD 483.32 million in 2022 and will reach USD 1.23 billion by 2030, registering a CAGR of 12.4% for the forecast period 2023-2030.

Preview of Global Particle Therapy Market Revenue

Particle Therapy Market Size, CAGR and Industry Statistics

Base Year	2023
Historical Data Time Period	2019-2023
Forecast Period	2024-2031
Global Particle Therapy Market Sales Revenue 2022	$ 483.32 Billion
Global Particle Therapy Market Sales Revenue 2030	$ 1.23 Billion
Global Particle Therapy Market Compound Annual Growth Rate (CAGR) for 2024 to 2031	12.4%

Industry segmentation can be altred as per your needs. For example, we can proivde cross slipt between Proton therapy with Application, Product, additional country analysis, volume/consumption data, etc.

Particle Therapy Market Report Scope

Market Split by Type	Proton therapy Heavy ion therapy
Market Split by Application	Treatment Research
Market Split by Product	Cycloclotron Synchrotron Synchrocyclotron
Market Split by Cancer Type	Pediatric cancer Lung cancer Bladder cancer Head and neck cancer Gastrointestinal cancer
Market Split by End-User	Hospitals Academic & Research centers
Market Split by System Type	Single-room Multi-room
List of Competitors	Varian Medical Systems Ion Beam Applications Sa (IBA) Mevion Medical Systems Inc. Provision Healthcare LLC Sumitomo Heavy Industries Ltd. Hitachi Ltd. Optivus Proton Therapy Inc. Protom International Inc. Advanced Oncotherapy PLC. Danfysik A/S Confidential Data Access The Paid Version Data Hidden
Regional Analysis	North America Europe Asia-Pacific South America Middle East and Africa
Country Analysis	North America (United States, Canada, Mexico) Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC) South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America) Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Key Qualitative Information Covered	Market Trends Market Drivers Market Restraints Market Opportunity Market Attractiveness Analysis COVID–19 Impact and Recovery Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis Patent Analysis ESG Analysis

Report scope is customizable as we have a huge database of Particle Therapy industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Particle Therapy Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!

Particle Therapy Market Report Description

What is Particle Therapy?

Particle therapy is a type of radiation therapy in which high-powered energy is used to treat cancer and some non-cancerous tumors. Radiation therapy using proton and carbon ions provides physical characteristics allowing for a volume conformal irradiation and a Reduction of the Integral dose to normal tissue. The particle device consists of a circular, accelerator, beamline, energy selection system, and patient application system. The particles are accelerated by high-frequency electromagnetic waves. As the protons move through the body, they slowly interact with electrons and release energy. The point where the highest energy release is known as the ‘Bragg peak’. A physician can designate the Bragg peak’s location, causing the most damage to the targeted tumor cells. The rise in clinical trials, advancement in radiotherapy, increase in the incidence of cancer, and a growing number of particle therapy centers provide lucrative growth to the particle therapy market.

The Driving factor of the Particle Therapy Market:

Rising prevalence of cancer

The rate of cancer is increasing at a higher rate propelling the market for particle therapy across the globe. According to WHO cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Breast cancer has 2.26 million cases, lung cancer has 2.21 cases, colon and rectum cases has 1.93 million cases, prostate cancer has 1.41 million cases, and skin cancer has 1.20 million cases. Each year, approximately 4 lakh children develop cancer. Cervical cancer is the most common in 23 countries. Ionizing radiation, smoking, consumption of alcohol, drinking water contaminants (arsenic), infection from viruses, bacteria, and aging are the causes of cancer. The risk of specific cancer increases with age. Growth in the number of elderly patients is propelling the market.

Advantages offered by particle therapy over traditional radiotherapy

There are a number of benefits to particle beam therapy over conventional photon therapy, particularly proton beam therapy. The market is expanding due to these benefits, particularly in developed economies where the adoption of advanced technology is strong. With the development of technologies like point scanning and motion tracking, the areas of applicability for particle beam treatment are also growing. Spot scans greatly minimize the dosage exposure to the healthy tissue around the target, and real-time motion tracking makes it possible for physicians to maintain the target in the beam's path and deliver regulated radiation therapy.

Restraining Factor for the Particle Therapy Market:

High cost and technological challenges:

Installing particle treatment systems costs a lot of money and calls for extensive infrastructure. These machines need a lot of installation area since they are considerably larger than photon therapy systems (such as cyclotrons and synchrotrons). The particle treatment facility entails high costs for building, labor, and operating cost. As a result, only a few medical facilities in emerging and developing nations have access to advanced particle treatment equipment. The inability to distinguish the tumor from normal and healthy tissue and to clearly visualize the tumor is one of the main problems with particle treatment. However, it is highly challenging to irradiate just malignant growth without damaging adjacent tissues since tumors can change form on a regular basis. The radiologist places a safety buffer around the tumor to reduce this. These are the factors that are hampering the market.

Impact of the COVID-19 Pandemic on the Particle Therapy Market:

COVID-19's impact on the particle therapy market was positive. The post-pandemic condition in particle therapy is a rising need for consumer radiation therapy. According to data, COVID-19 affected the regular supply of proton therapy which leads to delays and cancellation of procedures. After the lockdown growth of the market increased due to the high prevalence of cancer.

We have various report editions of Particle Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Particle Therapy Market Insights Video

Particle Therapy Market News

May 2023

The first heavy ion therapy system in Taiwan started treatment at Taipei veterans general hospital

This new system is able to provide higher-quality medical services by providing two well-equipped treatment rooms with horizontal ports. It is designed to provide image-gating motion management by which physicians can treat tumors in motion due to respiration, also advanced spot scanning technology.

October 2022

Siteman cancer center expanded proton therapy treatment

Siteman cancer center expanded proton therapy for patients by adding the latest advanced technology to its S. Lee Kling proton therapy center that will allow pencil beam scanning which delivers narrow proton beams aimed directly at the tumor with adjusted intensity.

Top Companies Market Share in Particle Therapy Industry: (In no particular order of Rank)

Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems Inc.
Provision Healthcare LLC
Sumitomo Heavy Industries Ltd.
Hitachi Ltd.
Optivus Proton Therapy Inc.
Protom International Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Confidential Data
Access The Paid Version
Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Particle Therapy Market

North America dominates the overall market:

The North American medical devices market is primarily driven by the rising patient population suffering from cancer throughout the region and the rising number of radiotherapies conducted each year. According to the national association for proton therapy, proton therapy is the most widely used particle therapy in the U.S. and over 75,000 patients have been treated with proton therapy. 38 centers are providing proton therapy in North America. Cancer is mostly brought on by an increase in sedentary lifestyle adoption as well as increased drug, alcohol, and tobacco use in North America also improved infrastructure of healthcare is further boosting the market growth in the region.

The current report Scope analyzes Particle Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

North America (United States, Canada, Mexico)
Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

Particle Therapy Market Share (%) by Region (2019-2031)

The above graph is for illustrative purposes only.

To learn more about geographical trends request the free sample pages.

Get Free Sample

Particle Therapy Market Analysis

Global Particle Therapy Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Particle Therapy Industry growth. Particle Therapy market has been segmented with the help of its Type, Application Product, and others. Particle Therapy market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

The proton therapy segment dominated the market of particle therapy with the largest share

On the basis of type, particle therapy is segmented into proton therapy and heavy Ion therapy. Proton therapy is the dominant segment among the types of therapy during the forecast period. Protecting important neurological functions like memory and speech when the tumor is close to these areas, minimizing radiation to vital organs like the heart, and lungs while treating breast or spine cancer, reducing the risks for children suffering from cancer, and dealing with the side effects of toxic cancer treatment, helps to protect the areas which already had radiations these all the factors which results in proton therapy is gaining more popularity compared to conventional therapy.

Proton therapy
Heavy ion therapy

Particle Therapy Market Share (%) by Type in 2019-2031

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Particle Therapy Industry. Request a Free Sample PDF!

Particle Therapy Market, By Application

By application, the market is bifurcated into cyclotron, Synchrotron, and Synchrocyclotron. The cyclotron segment is the leading segment which accounted for the highest market share. This market category is anticipated to increase at a CAGR of 6.7% over the course of the forecast period, to have a share of 71.4% in the particle treatment market. The primary forces driving the development of this market segment are the advantages cyclotrons offer over other accelerators and the development of technologically advanced systems.

Treatment
Research

Particle Therapy Market Share (%) by Application in 2019-2031

2019

2023

2031

The above Graph is for representation purposes only. This chart does not depict actual Market share.

To learn more about market share request the free sample pages.

Get Free Sample

Particle Therapy Product Segment Analysis

Cycloclotron
Synchrotron
Synchrocyclotron

Particle Therapy Cancer Type Segment Analysis

Particle Therapy Market, By Cancer Type

The breast cancer segment held the largest market share

On the basis of cancer type, the market is divided into lungs, spinal cord, prostate, and breast. The breast cancer segment held the largest market share in terms of revenue. Breast cancer primarily threatens women’s health across the globe. In the year 2020 alone, 2.2 million female breast cancer cases were diagnosed. Photon therapy followed by lumpectomy is shown improvement in survival and lowering recurrence. According to meta-analysis data, 10801 breast cancer patients were treated with photon radiotherapy which effectively reduced the 10-year recurrence rate and 15-year survival rate.

Pediatric cancer
Lung cancer
Bladder cancer
Head and neck cancer
Gastrointestinal cancer

Particle Therapy End-User Segment Analysis

Particle Therapy Market, By End-User

The hospital segment accounted for the largest share

Hospitals are the primary health systems and the rise in the hospital preference by the population for the detection and treatment of cancer boosts the growth of the segment. Advancement in infrastructure, adoption of new technologies related to radiotherapies, and increase in patient and elderly patient visits are the major factors for boosting the market's growth.

Hospitals
Academic & Research centers

Particle Therapy System Type Segment Analysis

Single-room
Multi-room

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Bio :

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.

In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.

Author's Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Particle Therapy Market is witnessing significant growth in the near future.

In 2023, the Proton therapy segment accounted for noticeable share of global Particle Therapy Market and is projected to experience significant growth in the near future.

The Treatment segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Varian Medical Systems, Mevion Medical Systems Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)

Which segment accounted for the largest share of the particle therapy market share?

Proton therapy is the dominant segment among the types of therapy during the forecast period. helps to protect the areas which already had radiations, protecting vital functions like memory and are the factor boosting the growth.

What are the major factors influencing the growth of the particle therapy market?

Major factors influencing the growth of the particle therapy market are the rise in clinical trials, advancement in radiotherapy, an increase in the incidence of cancer, and a growing number of particle therapy centers providing lucrative growth to the particle therapy market.

Who are the market leaders in the particle therapy market?

The major key players operating in the market are Mevion Medical Systems, Varian Medical Systems, Inc., Sumitomo Heavy Industries, Ltd, Hitachi, Ltd., Toshiba Medical Systems Corporation, Provision Healthcare, IBA Worldwide, LLC (US), and others

What market research methods have been used to analyze the complete market size?

The study involved in-depth qualitative and quantitative analyses of the market. Moreover, the research study involves the use of secondary sources and databases such as key companies’ annual reports, and paid & public databases, Market value evaluation is done by using top-down as well as bottom-up analysis.

Does the study include an examination of the COVID-19 impacts?

Yes, the report includes a COVID-19 impact analysis.

What is the study period of this market?

The report has been analyzed from the year 2018 to 2030 in which 2018-2021: Historic Period 2022: Base Year 2023-2030: Forecast Period

Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.

Latest News about Particle Therapy Market

Sources from Medical Devices & Consumables Industry

Particle Therapy Market Report Table of Content

Disclaimer:

This is just a redacted sample pages of the actual deliverable report and only for representative purposes
Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Report Scope

Type	Proton therapy, Heavy ion therapy
Application	Treatment, Research
Product	Cycloclotron, Synchrotron, Synchrocyclotron
Cancer Type	Pediatric cancer, Lung cancer, Bladder cancer, Head and neck cancer, Gastrointestinal cancer
End-User	Hospitals, Academic & Research centers
System Type	Single-room, Multi-room
List of Competitors	Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems Inc., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., Hitachi Ltd., Optivus Proton Therapy Inc., Protom International Inc., Advanced Oncotherapy PLC., Danfysik A/S

Expand All

This chapter will help you gain GLOBAL Market Analysis of Particle Therapy. Further deep in this chapter, you will be able to review Global Particle Therapy Market Split by various segments and Geographical Split.

Chapter 1 Global Market Analysis

1.1 Global Particle Therapy Market Size, Trend Analysis 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

1.2 Global Particle Therapy Market Size By Regions 2019 - 2031
- 1.2.1 Global Particle Therapy Revenue Market Size By Region
1.3 Global Particle Therapy Market Size By Type 2019 -2031
- 1.3.1 Proton therapy Market Size
- 1.3.2 Heavy ion therapy Market Size
1.4 Global Particle Therapy Market Size By Application 2019 -2031
- 1.4.1 Treatment Market Size
- 1.4.2 Research Market Size
1.5 Global Particle Therapy Market Size By Product 2019 -2031
- 1.5.1 Cycloclotron Market Size
- 1.5.2 Synchrotron Market Size
- 1.5.3 Synchrocyclotron Market Size
1.6 Global Particle Therapy Market Size By Cancer Type for 2019 -2031
- 1.6.1 Pediatric cancer Market Size
- 1.6.2 Lung cancer Market Size
- 1.6.3 Bladder cancer Market Size
- 1.6.4 Head and neck cancer Market Size
- 1.6.5 Gastrointestinal cancer Market Size
1.7 Global Particle Therapy Market Size By End-User for 2019 -2031
- 1.7.1 Hospitals Market Size
- 1.7.2 Academic & Research centers Market Size
1.8 Global Particle Therapy Market Size By System Type for 2019 -2031
- 1.8.1 Single-room Market Size
- 1.8.2 Multi-room Market Size
- 1.8.1 Single-room Market Size
- 1.8.2 Multi-room Market Size
1.9 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

1.10 Executive Summary Global Market (2019 vs 2024 vs 2031)
- 1.10.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
- 1.10.2 Global Market Revenue Split By Type
- 1.10.3 Global Market Revenue Split By Application
- 1.10.4 Global Market Revenue Split By Product
- 1.10.5 Global Market Revenue Split By Cancer Type
- 1.10.6 Global Market Revenue Split By End-User
- Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
  
  1.10.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

Chapter 2 North America Market Analysis

2.1 North America Particle Therapy Market Size 2019 - 2031
- 2.1.1 North America Particle Therapy Market Size By Country 2019 - 2031
- 2.1.2 North America Particle Therapy Market Size by Type 2019 -2031
  - 2.1.2.1 North America Proton therapy Market Size
  - 2.1.2.2 North America Heavy ion therapy Market Size
- 2.1.3 North America Particle Therapy Market Size by Application 2019 -2031
  - 2.1.3.1 North America Treatment Market Size
  - 2.1.3.2 North America Research Market Size
- 2.1.4 North America Particle Therapy Market Size by Product 2019 -2031
  - 2.1.4.1 North America Cycloclotron Market Size
  - 2.1.4.2 North America Synchrotron Market Size
  - 2.1.4.3 North America Synchrocyclotron Market Size
- 2.1.5 North America Particle Therapy Market Size by Cancer Type 2019 -2031
  - 2.1.5.1 North America Pediatric cancer Market Size
  - 2.1.5.2 North America Lung cancer Market Size
  - 2.1.5.3 North America Bladder cancer Market Size
  - 2.1.5.4 North America Head and neck cancer Market Size
  - 2.1.5.5 North America Gastrointestinal cancer Market Size
- 2.1.6 North America Particle Therapy Market Size by End-User 2019 -2031
  - 2.1.6.1 North America Hospitals Market Size
  - 2.1.6.2 North America Academic & Research centers Market Size
- 2.1.7 North America Particle Therapy Market Size by System Type 2019 -2031
  - 2.1.7.1 North America Single-room Market Size
  - 2.1.7.2 North America Multi-room Market Size

Chapter 3 Europe Market Analysis

3.1 Europe Particle Therapy Market Size 2019 - 2031
- 3.1.1 Europe Particle Therapy Market Size By Country 2019 - 2031
- 3.1.2 Europe Particle Therapy Market Size by Type 2019 -2031
  - 3.1.2.1 Europe Proton therapy Market Size
  - 3.1.2.2 Europe Heavy ion therapy Market Size
- 3.1.3 Europe Particle Therapy Market Size by Application 2019 -2031
  - 3.1.3.1 Europe Treatment Market Size
  - 3.1.3.2 Europe Research Market Size
- 3.1.4 Europe Particle Therapy Market Size by Product 2019 -2031
  - 3.1.4.1 Europe Cycloclotron Market Size
  - 3.1.4.2 Europe Synchrotron Market Size
  - 3.1.4.3 Europe Synchrocyclotron Market Size
- 3.1.5 Europe Particle Therapy Market Size by Cancer Type 2019 -2031
  - 3.1.5.1 Europe Pediatric cancer Market Size
  - 3.1.5.2 Europe Lung cancer Market Size
  - 3.1.5.3 Europe Bladder cancer Market Size
  - 3.1.5.4 Europe Head and neck cancer Market Size
  - 3.1.5.5 Europe Gastrointestinal cancer Market Size
- 3.1.6 Europe Particle Therapy Market Size by End-User 2019 -2031
  - 3.1.6.1 Europe Hospitals Market Size
  - 3.1.6.2 Europe Academic & Research centers Market Size
- 3.1.7 Europe Particle Therapy Market Size by System Type 2019 -2031
  - 3.1.7.1 Europe Single-room Market Size
  - 3.1.7.2 Europe Multi-room Market Size

Chapter 4 Asia Pacific Market Analysis

4.1 Asia Pacific Particle Therapy Market Size 2019 - 2031
- 4.1.1 Asia Pacific Particle Therapy Market Size By Country 2019 - 2031
- 4.1.2 Asia Pacific Particle Therapy Market Size by Type 2019 -2031
  - 4.1.2.1 Asia Pacific Proton therapy Market Size
  - 4.1.2.2 Asia Pacific Heavy ion therapy Market Size
- 4.1.3 Asia Pacific Particle Therapy Market Size by Application 2019 -2031
  - 4.1.3.1 Asia Pacific Treatment Market Size
  - 4.1.3.2 Asia Pacific Research Market Size
- 4.1.4 Asia Pacific Particle Therapy Market Size by Product 2019 -2031
  - 4.1.4.1 Asia Pacific Cycloclotron Market Size
  - 4.1.4.2 Asia Pacific Synchrotron Market Size
  - 4.1.4.3 Asia Pacific Synchrocyclotron Market Size
- 4.1.5 Asia Pacific Particle Therapy Market Size by Cancer Type 2019 -2031
  - 4.1.5.1 Asia Pacific Pediatric cancer Market Size
  - 4.1.5.2 Asia Pacific Lung cancer Market Size
  - 4.1.5.3 Asia Pacific Bladder cancer Market Size
  - 4.1.5.4 Asia Pacific Head and neck cancer Market Size
  - 4.1.5.5 Asia Pacific Gastrointestinal cancer Market Size
- 4.1.6 Asia Pacific Particle Therapy Market Size by End-User 2019 -2031
  - 4.1.6.1 Asia Pacific Hospitals Market Size
  - 4.1.6.2 Asia Pacific Academic & Research centers Market Size
- 4.1.7 Asia Pacific Particle Therapy Market Size by System Type 2019 -2031
  - 4.1.7.1 Asia Pacific Single-room Market Size
  - 4.1.7.2 Asia Pacific Multi-room Market Size

Chapter 5 South America Market Analysis

5.1 South America Particle Therapy Market Size 2019 - 2031
- 5.1.1 South America Particle Therapy Market Size By Country 2019 - 2031
- 5.1.2 South America Particle Therapy Market Size by Type 2019 -2031
  - 5.1.2.1 South America Proton therapy Market Size
  - 5.1.2.2 South America Heavy ion therapy Market Size
- 5.1.3 South America Particle Therapy Market Size by Application 2019 -2031
  - 5.1.3.1 South America Treatment Market Size
  - 5.1.3.2 South America Research Market Size
- 5.1.4 South America Particle Therapy Market Size by Product 2019 -2031
  - 5.1.4.1 South America Cycloclotron Market Size
  - 5.1.4.2 South America Synchrotron Market Size
  - 5.1.4.3 South America Synchrocyclotron Market Size
- 5.1.5 South America Particle Therapy Market Size by Cancer Type 2019 -2031
  - 5.1.5.1 South America Pediatric cancer Market Size
  - 5.1.5.2 South America Lung cancer Market Size
  - 5.1.5.3 South America Bladder cancer Market Size
  - 5.1.5.4 South America Head and neck cancer Market Size
  - 5.1.5.5 South America Gastrointestinal cancer Market Size
- 5.1.6 South America Particle Therapy Market Size by End-User 2019 -2031
  - 5.1.6.1 South America Hospitals Market Size
  - 5.1.6.2 South America Academic & Research centers Market Size
- 5.1.7 South America Particle Therapy Market Size by System Type 2019 -2031
  - 5.1.7.1 South America Single-room Market Size
  - 5.1.7.2 South America Multi-room Market Size

Chapter 6 Middle East and Africa Market Analysis

6.1 Middle East and Africa Particle Therapy Market Size 2019 - 2031
- 6.1.1 Middle East and Africa Particle Therapy Market Size By Country 2019 - 2031
- 6.1.2 Middle East and Africa Particle Therapy Market Size by Type 2019 -2031
  - 6.1.2.1 Middle East and Africa Proton therapy Market Size
  - 6.1.2.2 Middle East and Africa Heavy ion therapy Market Size
- 6.1.3 Middle East and Africa Particle Therapy Market Size by Application 2019 -2031
  - 6.1.3.1 middle_east_and_africa_title} Treatment Market Size
  - 6.1.3.2 middle_east_and_africa_title} Research Market Size
- 6.1.4 Middle East and Africa Particle Therapy Market Size by Product 2019 -2031
  - 6.1.4.1 Middle East and Africa Cycloclotron Market Size
  - 6.1.4.2 Middle East and Africa Synchrotron Market Size
  - 6.1.4.3 Middle East and Africa Synchrocyclotron Market Size
- 6.1.5 Middle East and Africa Particle Therapy Market Size by Cancer Type 2019 -2031
  - 6.1.5.1 Middle East and Africa Pediatric cancer Market Size
  - 6.1.5.2 Middle East and Africa Lung cancer Market Size
  - 6.1.5.3 Middle East and Africa Bladder cancer Market Size
  - 6.1.5.4 Middle East and Africa Head and neck cancer Market Size
  - 6.1.5.5 Middle East and Africa Gastrointestinal cancer Market Size
- 6.1.6 Middle East and Africa Particle Therapy Market Size by End-User 2019 -2031
  - 6.1.6.1 Middle East and Africa Hospitals Market Size
  - 6.1.6.2 Middle East and Africa Academic & Research centers Market Size
- 6.1.7 Middle East and Africa Particle Therapy Market Size by System Type 2019 -2031
  - 6.1.7.1 Middle East and Africa Single-room Market Size
  - 6.1.7.2 Middle East and Africa Multi-room Market Size

Only Available with Corporate User License

Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)

7.1 Country 1 Market Analysis
- 7.1.1 Country 1Particle Therapy Market Size by Type 2019 -2031
- 7.1.2 Country 1Particle Therapy Market Size by Application 2019 -2031
- 7.1.3 Country 1Particle Therapy Market Size by Product 2019 -2031
- 7.1.4 Country 1Particle Therapy Market Size by Cancer Type 2019 -2031
- 7.1.5 Country 1Particle Therapy Market Size by End-User 2019 -2031
- 7.1.6 Country 1Particle Therapy Market Size by System Type 2019 -2031
7.2 Country 2 Market Analysis
- 7.2.1 Segmentation Analysis will be provided as shown for Country 1
7.3 Country 3 Market Analysis
- 7.3.1 Segmentation Analysis will be provided as shown for Country 1
7.4 Country 4 Market Analysis
- 7.4.1 Segmentation Analysis will be provided as shown for Country 1
7.5 Country 5 Market Analysis
- 7.5.1 Segmentation Analysis will be provided as shown for Country 1
7.6 Country 6 Market Analysis
- 7.6.1 Segmentation Analysis will be provided as shown for Country 1
7.7 Country 7 Market Analysis
- 7.7.1 Segmentation Analysis will be provided as shown for Country 1
7.8 Country 8 Market Analysis
- 7.8.1 Segmentation Analysis will be provided as shown for Country 1
7.9 Country 9 Market Analysis
- 7.9.1 Segmentation Analysis will be provided as shown for Country 1
7.10 Country 10 Market Analysis
- 7.10.1 Segmentation Analysis will be provided as shown for Country 1

Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)

Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))

8.1 Top Competitors Analysis
- 8.1.1 Top Players Ranking 2022
- (Subject to Data Availability (Private Players))
  
  8.1.2 Global Particle Therapy Market Revenue and Share by Manufacturers (2019-2023)
- 8.1.3 Industry Mergers and Acquisition Analysis
- 8.1.4 New Product Launch Analysis
8.2 Company Profile (Data Subject to Availability)
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.1 Varian Medical Systems
  - 8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.1.2 Business Overview
  - 8.2.1.3 Financials (Subject to data availability)
  - 8.2.1.4 Product Types Specification
  - 8.2.1.5 Business Strategy
  - 8.2.1.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.2 Ion Beam Applications Sa (IBA)
  - 8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.2.2 Business Overview
  - 8.2.2.3 Financials (Subject to data availability)
  - 8.2.2.4 Product Types Specification
  - 8.2.2.5 Business Strategy
  - 8.2.2.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.3 Mevion Medical Systems Inc.
  - 8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.3.2 Business Overview
  - 8.2.3.3 Financials (Subject to data availability)
  - 8.2.3.4 Product Types Specification
  - 8.2.3.5 Business Strategy
  - 8.2.3.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.4 Provision Healthcare LLC
  - 8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.4.2 Business Overview
  - 8.2.4.3 Financials (Subject to data availability)
  - 8.2.4.4 Product Types Specification
  - 8.2.4.5 Business Strategy
  - 8.2.4.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.5 Sumitomo Heavy Industries Ltd.
  - 8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.5.2 Business Overview
  - 8.2.5.3 Financials (Subject to data availability)
  - 8.2.5.4 Product Types Specification
  - 8.2.5.5 Business Strategy
  - 8.2.5.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.6 Hitachi Ltd.
  - 8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.6.2 Business Overview
  - 8.2.6.3 Financials (Subject to data availability)
  - 8.2.6.4 Product Types Specification
  - 8.2.6.5 Business Strategy
  - 8.2.6.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.7 Optivus Proton Therapy Inc.
  - 8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.7.2 Business Overview
  - 8.2.7.3 Financials (Subject to data availability)
  - 8.2.7.4 Product Types Specification
  - 8.2.7.5 Business Strategy
  - 8.2.7.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.8 Protom International Inc.
  - 8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.8.2 Business Overview
  - 8.2.8.3 Financials (Subject to data availability)
  - 8.2.8.4 Product Types Specification
  - 8.2.8.5 Business Strategy
  - 8.2.8.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.9 Advanced Oncotherapy PLC.
  - 8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.9.2 Business Overview
  - 8.2.9.3 Financials (Subject to data availability)
  - 8.2.9.4 Product Types Specification
  - 8.2.9.5 Business Strategy
  - 8.2.9.6 S.W.O.TAnalysis
- Data Subject to Availability as we consider Top competitors and their market share will be delivered.
  
  8.2.10 Danfysik A/S
  - 8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
  - 8.2.10.2 Business Overview
  - 8.2.10.3 Financials (Subject to data availability)
  - 8.2.10.4 Product Types Specification
  - 8.2.10.5 Business Strategy
  - 8.2.10.6 S.W.O.TAnalysis

Chapter 9 Qualitative Analysis (Subject to Data Availability)

9.1 Market Drivers
9.2 Market Trends
9.3 Market Restraints
9.4 Market Opportunity
9.5 Product Life Cycle (Subject to Data Availability)
9.6 Industrial Chain Analysis (Subject to Data Availability)
- 9.6.1 Industry Chain Analysis
- 9.6.2 Manufacturing Cost Analysis
- 9.6.3 Consumer Preference Analysis
- 9.6.4 Supply Side Analysis
  - 9.6.4.1 Raw Material Analysis
  - 9.6.4.2 Raw Material Procurement Analysis
  - 9.6.4.3 Raw Material Price Trend Analysis
9.7 Market Attractiveness Analysis
9.8 PESTEL Analysis
9.9 Porter’s Five Forces Analysis
9.10 Patent Analysis (Subject to Data Availability)
9.11 ESG Analysis
9.12 Technological Road Map

Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.

Chapter 10 Market Split by Type Analysis 2019 -2031

10.1 Proton therapy
- 10.1.1 Global Particle Therapy Revenue Market Size and Share by Proton therapy 2019 -2031
10.2 Heavy ion therapy
- 10.2.1 Global Particle Therapy Revenue Market Size and Share by Heavy ion therapy 2019 -2031

The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.

Chapter 11 Market Split by Application Analysis 2019 -2031

11.1 Treatment
- 11.1.1 Global Particle Therapy Revenue Market Size and Share by Treatment 2019 - 2031
11.2 Research
- 11.2.1 Global Particle Therapy Revenue Market Size and Share by Research 2019 - 2031

Chapter 12 Market Split by Product Analysis 2019 -2031

12.1 Cycloclotron
- 12.1.1 Global Particle Therapy Revenue Market Size and Share by Cycloclotron 2019 -2031
12.2 Synchrotron
- 12.2.1 Global Particle Therapy Revenue Market Size and Share by Synchrotron 2019 -2031
12.3 Synchrocyclotron
- 12.3.1 Global Particle Therapy Revenue Market Size and Share by Synchrocyclotron 2019 -2031

Chapter 13 Market Split by Cancer Type Analysis 2019 -2031

13.1 Pediatric cancer
- 13.1.1 Global Particle Therapy Revenue Market Size and Share by Pediatric cancer 2019 -2031
13.2 Lung cancer
- 13.2.1 Global Particle Therapy Revenue Market Size and Share by Lung cancer 2019 -2031
13.3 Bladder cancer
- 13.3.1 Global Particle Therapy Revenue Market Size and Share by Bladder cancer 2019 -2031
13.4 Head and neck cancer
- 13.4.1 Global Particle Therapy Revenue Market Size and Share by Head and neck cancer 2019 -2031
13.5 Gastrointestinal cancer
- 13.5.1 Global Particle Therapy Revenue Market Size and Share by Gastrointestinal cancer 2019 -2031

Chapter 14 Market Split by End-User Analysis 2019 -2031

14.1 Hospitals
- 14.1.1 Global Particle Therapy Revenue Market Size and Share by Hospitals 2019 -2031
14.2 Academic & Research centers
- 14.2.1 Global Particle Therapy Revenue Market Size and Share by Academic & Research centers 2019 -2031

Chapter 15 Market Split by System Type Analysis 2019 -2031

15.1 Single-room
- 15.1.1 Global Particle Therapy Revenue Market Size and Share by Single-room 2019 -2031
15.2 Multi-room
- 15.2.1 Global Particle Therapy Revenue Market Size and Share by Multi-room 2019 -2031

This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Particle Therapy market

Chapter 16 Research Findings

16.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

16.2 Analyst Point of View
16.3 Assumptions and Acronyms